Tel: 0755-85269922 E-mail: sales@biochemmall.com
ICP:粤ICP备19135875号
Lenvatinib Mesylate is a synthetic, orally available inhibitor of VEGFR2 tyrosine kinase with potential antineoplastic activity.
Brand: BCM
Solubility: Soluble in DMSO.
InChIKey: HWLFIUUAYLEFCT-UHFFFAOYSA-N
InChI: InChI=1S/C21H19ClN4O4.CH4O3S/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11;1-5(2,3)4/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28);1H3,(H,2,3,4)
Attribute [CAS No.] 857890-39-2 [MDL No.] MFCD18633219 [Formula] C22H23ClN4O7S [Molecular] 522.96 [Chem Name] 4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide methanesulfonate [Synonym] Lenvatinib Mesylate [Storage] Sealed in dry. -20°C Freezer [EINECS] 812-398-0 [Form] White to Off-White Powder
Goods Tag